In January 2008, AcryMed Inc was acquired by I-Flow Corp. of Lake Forest, CA. The following year - 2009 - I-flow was acquired by Kimberley Clark Healthcare - since renamed Halyard - itself now part of Owens & Minor,. AcryMed had been focused on the introduction of novel medical products that help heal wounds or reduce infections: products comingout of from its proprietary technologies through clinical investigation, regulatory clearance, and manufacturing development. The firm's stratgey had been to seek marketing partners around the world to sell and distribute AcryMed's products. while in some instances licenses its technologies to companies that want to enhance their own products. The company developed a proprietary skin substitute material branded Microlattice®: foundation for the company's first commercial product, an advanced moist wound care dressing marketed initially under the AcryDerm brand and then in the U.S. by Smith & Nephew under the FlexiGel® brand. If the wound too dry product donates moisture; too wet it absorbs excess moisture to provide a healthy environment for healing wounds. In addition to this moisture management capability, Microlattice matrix is also an optimal vehicle to deliver active agents to the body over an extended time. A wide range of active agents have successfully been integrated into Microlattice to produce devices that deliver therapeutically significant quantities of agents ranging from elemental oxygen to protein growth factors. The first commercially available products using this approach are the SilvaSorb® silver antimicrobial dressings and gel which incorporate AcryMed's proprietary stabilized silver chemistry
